Pfizer has a made a $48 per share play for Array Biopharma, which values the cancer specialist at $11.4 billion. The offer – which is a 62% premium over Array’s closing share price on Friday – would ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results